TABLE OF CONTENTS
Volume 12, Issue 4 (April 2005)
Original Articles
Tumor cells as cellular vehicles to deliver gene therapies to metastatic tumors
Javier García-Castro, Jesús Martínez-Palacio, Rosa Lillo, Félix García-Sánchez, Ramón Alemany, Luis Madero, Juan A Bueren and Manuel Ramírez
Cancer Gene Ther 12: 341-349; advance online publication, January 14, 2005; doi:10.1038/sj.cgt.7700801
Systemic therapy of experimental breast cancer metastases by mutant vesicular stomatitis virus in immune-competent mice
Oliver Ebert, Sonal Harbaran, Katsunori Shinozaki and Savio L C Woo
Cancer Gene Ther 12: 350-358; advance online publication, November 26, 2004; doi:10.1038/sj.cgt.7700794
Enhanced inhibition of syngeneic murine tumors by combinatorial therapy with genetically engineered HSV-1 expressing CCL2 and IL-12
Jacqueline N Parker, Sreelatha Meleth, Kenneth B Hughes, G Yancey Gillespie, Richard J Whitley and James M Markert
Cancer Gene Ther 12: 359-368; advance online publication, January 28, 2005; doi:10.1038/sj.cgt.7700784
A multiprong approach to cancer gene therapy by coencapsulated cells
Pasquale Cirone, Feng Shen and Patricia L Chang
Cancer Gene Ther 12: 369-380; advance online publication, February 4, 2005; doi:10.1038/sj.cgt.7700786
Modulation of retrovirally driven therapeutic genes by mutant TP53 in anaplastic thyroid carcinoma
Luisa Barzon, Elisa Gnatta, Ignazio Castagliuolo, Marta Trevisan, Fabiola Moretti, Alfredo Pontecorvi, Marco Boscaro and Giorgio Palù
Cancer Gene Ther 12: 381-388; advance online publication, January 14, 2005; doi:10.1038/sj.cgt.7700789
Restoring DNA repair capacity of cells from three distinct diseases by XPD gene-recombinant adenovirus
Melissa Gava Armelini, Alysson Renato Muotri, Maria Carolina Nasser Marchetto, Keronninn Moreno de Lima-Bessa, Alain Sarasin and Carlos Frederico Martins Menck
Cancer Gene Ther 12: 389-396; advance online publication, January 14, 2005; doi:10.1038/sj.cgt.7700797
Adenovirus-mediated p53 gene therapy in pediatric soft-tissue sarcoma cell lines: sensitization to cisplatin and doxorubicin
Hooman Ganjavi, Matthew Gee, Aru Narendran, Melvin H Freedman and David Malkin
Cancer Gene Ther 12: 397-406; advance online publication, December 24, 2004; doi:10.1038/sj.cgt.7700798
Widespread intratumoral virus distribution with fractionated injection enables local control of large human rhabdomyosarcoma xenografts by oncolytic herpes simplex viruses
Mark A Currier, Lisa C Adams, Yonatan Y Mahller and Timothy P Cripe
Cancer Gene Ther 12: 407-416; advance online publication, January 21, 2005; doi:10.1038/sj.cgt.7700799
p73
-expressing recombinant adenovirus: a potential anticancer agent
Sanjeev Das, Srikanth Nama, Sini Antony and Kumaravel Somasundaram
Cancer Gene Ther 12: 417-426; advance online publication, January 28, 2005; doi:10.1038/sj.cgt.7700803
Murine mammary adenocarcinoma cells transfected with p53 and/or Flt3L induce antitumor immune responses
Hongxun Sang, Vladimir M Pisarev, Jennifer Chavez, Simon Robinson, Yajun Guo, Lori Hatcher, Corey Munger, Cathy B Talmadge, Joyce C Solheim, Rakesh K Singh and James E Talmadge
Cancer Gene Ther 12: 427-437; advance online publication, January 28, 2005; doi:10.1038/sj.cgt.7700809
